The possible relationship between changes in islet cell mass and in islet neogenesis-associated protein (INGAP)-cell mass induced by sucrose administration to normal hamsters was investigated. Normal hamsters were given sucrose (10% in drinking water) for 5 (S8) or 21 (S24) weeks and compared with control (C) fed hamsters. Serum glucose and insulin levels were measured and quantitative immunocytochemistry of the endocrine pancreas was performed. Serum glucose levels were comparable among the groups, while insulin levels were higher in S hamsters. There was a significant increase in -cell mass (P<0·02) and in -cell 5-bromo-2 -deoxyuridine index (P<0·01), and a significant decrease in islet volume (P<0·01) only in S8 vs C8 hamsters. Cytokeratin (CK)-labelled cells were detected only in S8 hamsters. INGAP-positive cell mass was significantly larger only in S8 vs C8 hamsters. Endocrine INGAP-positive cells were located at the islet periphery (96%), spread within the exocrine pancreas (3%), and in ductal cells (<1%) in all groups. INGAP positivity and glucagon co-localization varied according to topographic location and type of treatment. In C8 hamsters, 49·1 6·9% cells were INGAP-and glucagon-positive in the islets, while this percentage decreased by almost half in endocrine extra-insular and ductal cells. In S8 animals, co-expression increased in endocrine extra-insular cells to 36·3 9·5%, with similar figures in the islets, decreasing to 19·7 6·9% in ductal cells. INGAP-positive cells located at the islet periphery also co-expressed CK. In conclusion, a significant increase of INGAP-positive cell mass was only observed at 8 weeks when neogenesis was present, suggesting that this peptide might participate in the control of islet neogenesis. Thus, INGAP could be a potentially useful tool to treat conditions in which there is a decrease in -cell mass.
Introduction
-cell mass is the result of a final rate between opposed mechanisms such as growth and destruction. New cells can be formed by either mitotic division of pre-existing differentiated cells (replication), or differentiation from a developmental precursor or stem cell (neogenesis) (Bonner-Weir 1994 , Bouwens & Klöppel 1996 , Leahy 1996 .
A wide variety of processes, such as partial pancreatectomy (Cardezza & Rodríguez 1949 , Lee et al. 1989 , infusion of glucose solutions , dietary manipulation (Lombardo et al. 1983 , Luo et al. 1998 , normal pregnancy (Parsons et al. 1992) , pancreatic duct ligation (Wang et al. 1995) , wrapping of the pancreas head in cellophane (Rosenberg et al. 1983) , and sulfonylurea administration (Loubatieres 1964) , stimulate -cell growth (Swenne 1982 , BonnerWeir 1994 . Understanding the precise mechanism underlying these changes -particularly those obtained by modifying food intake -becomes of great interest, especially within the context of prevention (Pan et al. 1997) and treatment (Salmerón et al. 1997) of type 2 diabetes.
Several genes, hormones and growth factors are involved in the control of this growth process (Nielsen & Serup 1998) . One of these factors, islet neogenesisassociated protein (INGAP) has been identified as part of a protein complex called ilotropin, isolated from pancreata of normal hamsters previously wrapped in cellophane (CW) (Pittenger et al. 1991) . CW of the adult hamster pancreas led to the induction of new islet formations from ducts within 2 weeks with recapitulation of normal ontogeny (Bonner-Weir et al. 1993 , Bonner-Weir & Smith 1994 , Rosenberg et al. 1995 , Leahy 1996 in the absence of an inflammatory response . Thus, the appearance of INGAP is not the consequence of a previous acute pancreatitis, as is the case with the PAP (pancreatitis associated protein) and Reg/PSP families of genes (Gross et al. 1985 , Giorgi et al. 1989 , Terazono et al. 1990 , Orelle et al. 1992 .
It has recently been shown that INGAP is the product of a gene expressed in acinar cells but not in islets of regenerating hamster pancreata (Rafaeloff et al. 1997) . Administration of ilotropin causes recapitulation of normal islet ontogeny and reverses streptozotocin (STZ)-induced diabetes mortality by 50% (Swenne 1982 , Rosenberg et al. 1988 , Rafaeloff et al. 1997 ) through a paracrine or autocrine mechanism, rather than a hormonal one (Rosenberg et al. 1983 . These data suggest that INGAP is capable of initiating duct cell proliferation, a prerequisite for islet neogenesis.
We have previously shown that sucrose administration to normal rats (Lombardo et al. 1996) and hamsters (Del Zotto et al. 1998 , 1999 induces pancreas growth and islet neogenesis. However, it is not clear which factors are involved in the control of this process. Thus, in an attempt to gain new insight into this problem, we have studied the changes in glucose-induced islet growth and INGAP-cell mass by sustained administration of sucrose for a period of either 5 or 21 weeks to normal hamsters.
Materials and Methods
Twenty-four male Syrian hamsters weighing 30 2 g (23 days of age) were maintained in a temperaturecontrolled room (23 C) with a fixed 12-h light:darkness cycle (0600-1800 h). They were randomly divided into four groups: the two experimental groups had free access to a standard commercial diet plus 10% sucrose in the drinking water for 5 or 21 weeks (S8 and S24 respectively), whereas the two control groups received the same diet and tap water for the same periods (C8 and C24 respectively). Water intake was measured daily in all groups, while the body weight of each animal was recorded once a week throughout the experimental period.
Blood parameters
We measured glucose (glucose-oxidase method; Boehringer-Mannheim, Mannheim, Germany) and insulin (radioimmunoassay (Herbert et al. 1965) ) levels in serum from each animal at the time of killing (around 0900 h).
Morphological studies
After dissecting fat tissue away from the intact excised pancreas, we recorded the total wet weight. Samples of the pancreatic tail were fixed in Bouin's fluid and embedded in paraffin. Serial sections thinner than 5 µm were obtained from different levels of the block. After mounting each section from a given series on different slides, we stained adjacent sections for the immunocytochemical identification of and non-cells, cytokeratin-and 5-bromo-2 -deoxyuridine (BrdU)-labelled cells as well as INGAP-positive cells.
Identification of islet and non-cells
The following procedure was performed. Bouin-fixed, deparaffinized sections were treated with normal porcine serum to prevent non-specific staining and endogenous peroxidase was blocked with methanol/hydrogen peroxide; thereafter, the sections were incubated with appropriate dilutions of our own guinea-pig anti-insulin serum (1:20 000), plus a mixture of three other rabbit sera: antiglucagon (1:400), antipancreatic polypeptide (1:10 000) (both from Novo Nordisk A/G, Denmark), and antisomatostatin (1:6000) (Dako, Glostrup, Denmark).
Antigen retrieval (cytokeratin (CK) immunostaining)
Deparaffinized sections were pretreated with 250 ml antigen-retrieval solution (Vector Laboratories, Burlingame, CA, USA) for 10 min in a microwave oven (500 W). To reveal the presence of CK-positive cells, we used a panspecific cocktail of antibodies (1:40) against human CKs (clone AE1-AE3; Dako).
INGAP-reacting cells
Cells were identified using a specific rabbit antibody (IgG1246, 1:600) against a synthetic pentadecapeptide corresponding to amino acids 20-39 of the deduced INGAP protein sequence. The antibody was provided by Eli Lilly and Company, Indianapolis, IN, USA.
Islet cell replication rate
Islet cell replication rate was estimated in pancreatic sections obtained from animals previously injected with 25 mg/100 g BrdU (Sigma Co., St Louis, MO, USA) i.p., 1 h before killing (Gratzner 1982) . Sections were first incubated with BrdU-specific antibodies (1:100) (Cell Proliferation Kit-RPN 20; Amersham International plc, Amersham, Bucks, UK), and then the fraction of , non-, ductal and acinar cells was quantified among the labelled nuclei as described below. The replication raterelation between the total number of cells counted (no less than 3000) and BrdU-labelled cells -was expressed as the percentage of BrdU-labelled cells from the total of such cells.
In all these cases, unless specified in the figure legends, we used the streptavidin-biotin complex method (ABC; Dako), and carbazole as chromophore. Additionally, we verified serologic specificity by preincubating a given antiserum with an excess of either the corresponding hormone or BrdU for 24 h at 4 C, or by omitting the first peptide specific antibody in the immunostaining procedure.
Double immunolabelling studies
We followed two different procedures. (1) We performed double staining of the following pairs:
(insulin antibody) and non-cells (pool of glucagon+somatostatin+ pancreatic polypeptide (PP) antibodies); (insulin antibody) and BrdU (BrdU antibody); non-(antibodies pool) and BrdU (BrdU antibody). We used the streptavidinbiotin complex method, with peroxidase and alkaline phosphatase together with carbazole and fast-blue, respectively, as chromogens. Incubations with primary antibodies were overnight whereas those with the secondary biotinylated antibodies were for 30 min. (2) For serial double-immunofluorescence labelling, sections pretreated with non-immune sera from both rabbit and mouse diluted in Tris-buffered saline (pH 7·4) were incubated in a moist chamber at room temperature for 1 h with two of the hormone-specific antibodies in combination, one derived from mouse and the other from rabbit. The antibody pairs employed were: glucagon (1:50)+INGAP (1:300) (on the same section where insulin+BrdU had been previously tested); INGAP (1:300)+somatostatin (1:12·5); and INGAP (1:300)+PP (1:50). After washing with phosphate-buffered saline (PBS), fluorescence labelling of each of the pairs of primary antibodies was accomplished through a second incubation at room temperature for 45 min in the dark with the two IgG-specific florophore fluorescein-conjugated affinity-purified goat antibodies against rabbit IgG (heavy plus light chains; Jackson Immuno Research Laboratories, Inc., Baltimore, MD, USA), and rhodamine-conjugated affinity-purified goat antibody against mouse IgG (heavy plus light chains; Texas Red; Molecular Probes, Inc., Westgrove, PA, USA). After another washing with PBS, the sections were mounted in Tris-glycerol (pH 8·4) for analysis by fluorescence microscopy.
Morphometric analysis
We performed the morphometric analysis by videomicroscopy in combination with OPTIMAS (Bioscan Incorporated, Edmons, WA, USA) software in order to estimate the following parameters: total pancreas area excluding connective tissue (TP); the areas of endocrine (En) and exocrine (Ex) pancreas and of ( A) and non-(n A) cells; and islet volume (according to Hellman 1959) . We also calculated volume density of endocrine pancreas (En/TP); and volume density of ( A/TP) and non-(n A/TP) cells. To calculate the absolute and non-cell mass, the respective volume density was multiplied by the total weight of the pancreas . A similar procedure was used to measure INGAP-positive cell mass and to define its distribution within pancreatic cells.
Fluorescence optics
A Zeiss Axiolab epifluorescence microscope equipped with an HBO 50 mercury lamp was used. For visualization of fluorescein labelling, we employed two different filters to detect rhodamine and fluorescein fluorescence.
For the quantitative evaluation of immunofluorescence, positively labelled endocrine cells were counted under a 40 objective lens in sections made at different levels of the blocks. In each double-stained microscopic field, we counted, in succession, the cells that reacted positively for each one of the pairs of hormones tested, using first the appropriate set of filters for one of the fluorophores and then changing those filters to detect the other fluorescent probe. In doing so, we systematized our approach in such a way as to avoid scoring the same cell twice and thus were able to assess the total number of cells containing either or both of the hormones within each combination.
Statistical analysis
Results are expressed as the means ... The statistical significance was determined by Student's t-test. Differences were considered significant when P<0·05.
Results

Body weight and daily water intake
No significant differences were recorded in the body weights of control and sucrose-fed hamsters either at 8 (C8, 68·3 7·2 vs S8, 66·1 8·6 g) or 24 (C24, 103·53 5 vs S24, 116·28 5 g) weeks. The S8 group drank a significantly larger volume of water than the C8 group (48·2 2·3 vs 29·3 4 ml; P<0·005). Similar differences were recorded in S24 and C24 animals (74·54 1·3 vs 24·78 0·98 ml; P<0·001).
Quantitative and qualitative food ingestion
The total weight and the caloric content of the daily food consumed per animal were equivalent between the sucrose-fed and the control groups (11 vs 13 g respectively and 31 vs 33 Cal). As shown previously (Del Zotto et al. 1999) , and due to the presence of sucrose in the drinking water, the experimental animals received a qualitatively different daily intake of nutrients as compared with controls (carbohydrates:proteins:lipids, 61:30:9 vs 45:43:12 respectively).
Serum-glucose and insulin levels
The glucose levels measured in all the animals throughout this study were within the concentration range of 128 7 mg/dl found in our 20-week-old hamster colony (n=37) at the time of killing. In contrast, sucrosefed hamsters had higher insulin levels: in S8 hamsters the increase was almost fourfold (2·29 0·095 vs 0·62 0·029 ng/ml; P<0·001), but the difference was smaller in S24 hamsters (2·15 0·054 vs 1·38 0·067 ng/ ml; P<0·02). Due to the uneven behaviour of the blood glucose and insulin levels, great differences were recorded in the sucrose-fed groups relative to the corresponding control values in the insulin-glucose molar ratio (S8 vs C8, 5·3 10 9 vs 1·8 10 9 ; S24 vs C24, 5 10 9 vs 3·5 10 9 ).
Morphological studies
In all four groups, the pancreatic islets were composed of specifically stained endocrine cells, with cells occupying the central zone and non-cells located at the islet periphery. The islet shape ranged from round to ellipsoid, but the size was variable within a given histological section. A small number of ductal epithelial cells were positive for the insulin-specific antibody as well as for the pooled mixture of antisera against non-cell types.
Morphometric studies
There were no significant differences in C24 and S24 animals regarding the morphometric parameters, while the C8 and S8 hamsters differed significantly with respect to every parameter studied. The -cell mass was significantly greater in S8 vs C8 (4·2 0·2 vs 2·3 0·5 mg; P<0·01), with similar values recorded in S24 and C24 animals (3·4 0·3 vs 2·6 0·4 mg). As previously reported (Del Zotto et al. 1999) , significantly greater values were also recorded in S8 vs C8 in the number of islets per unit area (2·4 0·1 vs 1·2 0·1 mm 2 ; P<0·0004), and in -cell size (97 1·6 vs 88 3·1 µm 2 ; P<0·007). However, the islet volume in the S8 group was reduced to almost half that measured in C8 hamsters (38·9 3·4 vs 66·8 6·1 µm 3 , P<0·01). Similarly, the number of cells/islet was also significantly smaller in S8 than in C8 animals (S8 vs C8, 54 2 vs 87·8 5·6; P<0·002).
The -cell replication rate (BrdU incorporation) in S8 hamsters was tenfold that of C8 animals (P<0·007), but no significant differences were observed between S24 and C24 animals (Fig. 1) . No significant differences were found in the replication rate of non-cells within the islets between the S8 and the C8 groups (0·29 0·11 vs 0·26 0·14%; P=not significant (NS)). The BrdUincorporation rate within the exocrine pancreas (ductal, acinar, and centroacinar cells) was comparable between the S and the C groups (C8 vs S8, 3·3 0·2 vs 3·6 0·3, and C24 vs S24, 2·6 0·2 vs 3·1 0·4%).
As reported previously (Del Zotto et al. 1999) , comparable values were recorded in non-cell volume density, size, and mass in the control and in the sucrose-fed groups at any age (data not shown).
Presence of CKs in endocrine cells
Positive CK-stained cells, located at the islet periphery (in the -cell locale) and in the ductal cells, were only found in S8 animals (Fig. 2) , while no CK-positive cells were found in the islet periphery and in ductal cells in C8, C24 or S24 hamsters.
INGAP-positive cells
INGAP-positive cells were seen at the islet periphery (Fig.  3) , within the extra-insular endocrine cells and in the ductus (Fig. 4) . The mass of INGAP-positive cells was significantly larger in S8 than in C8 hamsters, while this difference disappeared in the mass of INGAP-positive cells in S24 animals (Table 1) .
Most INGAP-positive cells in all groups were located at the islet periphery (control vs sucrose, 96·1 0·7 vs 96·8 3·8, and 97·3 0·8 vs 97·7 0·9 at 8 and 24 weeks respectively), with a minor proportion spread within the extra-insular endocrine tissue (3·1 0·6 vs 2·6 0·9 and 2·0 0·8 vs 1·8 0·5) and in ductal cells (0·8 0·2 vs 0·6 0·2 and 0·7 0·3 vs 0·5 0·1). No significant differences were recorded between the two experimental groups at any of the topographic distributions of INGAP-positive cells.
A certain proportion of INGAP-positive cells simultaneously reacted with the glucagon antibody, but not with the insulin, somatostatin or PP antibodies (Fig. 5) . The frequency of glucagon co-expression in these cells varied according to their location and to the type of treatment received. In C8 hamsters, 49·1 6·9% of the INGAP-positive cells were glucagon-positive in the islets, while this percentage value markedly decreased to almost half in INGAP-positive cells located at extra-insular or ductal level (Table 2) . On the other hand, in the S8 animals the percentage of INGAP-positive cells that co-expressed glucagon increased in extra-insular endocrine cells to 36·3 9·5% -with similar figures in the islets (39·4 4·8%) -decreasing to 19·7 6·9% in duct cells.
INGAP-positive cells frequently co-expressed CKs, but none of them showed BrdU-labelled nuclei (data not shown).
Discussion
The current results confirm that after 5 weeks of sucrose feeding, the S8 hamsters showed an increase in total endocrine-pancreas mass stemming from islet neogenesis, -cell hypertrophy and hyperplasia (Del Zotto et al. 1998 , 1999 . As previously shown, these changes were accompanied by a modest increment in insulin release at lower glucose concentrations (Del Zotto et al. 1998 , 1999 . The increased total endocrine pancreas and -cell mass as well as the elevated -cell mitotic rates seen in the S8 hamsters did not increase further in the S24 animals; rather, these parameters became similar to those found in controls. Moreover, no signs of islet neogenesis -predominance of small-sized islets and presence of CK-labelled islet cells -were observed in the S24 animals, thus indicating that islet neogenesis no longer occurred at this time-period (Del Zotto et al. 1998 Zotto et al. , 1999 . CKs are expressed in the rat neonatal pancreas, where rapid pancreatic-islet growth occurs from the peri-islet mantle, but not within the region composed of mature endocrine cells ). In our study, similar results were obtained in the pancreas of normal hamsters (Del Zotto et al. 1999) ; CKs are therefore good markers of the neogenic zone from which layers of mantle cells derived from the ductal epithelium are added to the islet mass.
We have previously shown (Massa et al. 1997) , and later confirmed (Del Zotto et al. 1999) , that the endocrine pancreas of the normal hamster attains adult morphological and secretory patterns long after birth. Such patterns present a different time-sequence: the number of islets and the -cell mass reach adult characteristics at the age of 8 weeks with no further significant changes thereafter, while maximal glucose-induced insulin release is attained only at 24 weeks of age. This suggests that at each age, cells can cope efficiently with the metabolic demands through different adaptative mechanisms: early in life, islet growth plays a predominant role, but since islet growth would be restricted at 24 weeks, at that time the tissue can respond to a sustained insulin demand through an enhanced capacity to release insulin in response to glucose.
It is generally accepted that, during fetal and neonatal life, islets are newly formed from precursor cells that bud off from the pancreatic ductules (Swenne 1982 , Hellerström 1984 . Islet growth occurs at their periphery (Conklin 1962) , as observed in our S8 hamsters, where cells appear simultaneously labelled with glucagon and CK antibodies, the latter being useful markers to identify epithelial cell differentiation. As also found by other authors, only non-cells showed immunoreactivity for CKs in the islets, suggesting that these cells are likely to harbour the protodifferentiated stem cells . Our results therefore suggest that sucrose feeding duplicates fetal pancreatic development: islet cells originate within a peripheral neogenetic zone, 
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Ducts ( indicating that they not only bud off from the ducts, but their volume can further increase by adding consecutive layers of a CK-positive cell mantle derived from the ductal epithelium. An increased INGAP-positive cell mass was only observed in S8 hamsters, coinciding with clear signs of islet neogenesis. Further, there were no changes in this parameter in S24 hamsters when signs of neogenesis were no longer detected. The INGAP-positive cells were mainly located at the islet periphery, and they never showed a positive reaction with the BrdU antibody, but frequently did with the CK and glucagon antibodies. It is therefore tempting to speculate that they just added at the islet periphery after budding off from the ducts, and that INGAP-positive cells with no glucagon co-expression might still be at a less differentiated stage.
The other INGAP-positive endocrine cells coexpressing glucagon found at extra-insular level -also depicted only in S8 animals -might correspond to peripheral sections of the small-sized islets, which are characteristic of this experimental group. On the other hand, endocrine cells spread within the acinar tissue, reacting with the INGAP antibody but not with the glucagon antibody, might be cells that express the INGAP gene and have not yet differentiated into a specific islet hormone, or present hormone levels below the sensitivity of the detection method employed (Rafaeloff et al. 1997) .
Based on the significant increase in the INGAP-positive ductal-cell mass observed in the S8 hamsters, we expected to find an increased number of these cells labelled with BrdU. The absence of such a finding might be the consequence of a rather short S-phase of ductal compared with islet cells, which could handicap the chances of labelling when using the time-schedule suitable for islet cells. It might thus be important to sample tissues at earlier time-points.
We have previously reported that sustained sucrose feeding of normal rats (Lombardo et al. 1996) and hamsters (Del Zotto et al. 1998 , 1999 caused morphometric changes -indicative of islet neogenesis -similar to those currently described, while Rosenberg et al. (1988) observed that CW of adult hamster pancreata produced a 2·5-fold increase in islet-cell mass as a consequence of islet neogenesis. There were, however, some differences between CW (Pittenger et al. 1991) and our model: while in their control hamsters there was no INGAP expression and it appeared only after CW, INGAP-positive cells were already present in our control animals and their numbers increased significantly only when clear signs of neogenesis were present, i.e. in S8 hamsters. Differences in behaviour could probably be ascribed to the different strains employed by the two groups. For example, our hamsters have lower mean glucose levelsaround 130 mg/dl -compared with the 200 mg/dl in the Canadian Norfolk strain. The identification of INGAP-expressing cells in normal baboon fetuses and mouse embryos (Rafaeloff et al. 1998 ) also supports this assumption. Further differences were found between these two models: no apparent changes in peripheral insulin levels were reported in CW animals (Rosenberg & Vinik 1989 ), while our sucrose-treated hamsters exhibited elevated insulin levels together with normoglycaemia and a high insulin:glucose molar ratio, presumably reflecting a degree of insulin resistance (Del Zotto et al. 1998 , 1999 .
It has been shown that the combination of high serum insulin levels together with a high insulin:glucose molar ratio, as is the case in our sucrose-fed hamsters, represents a pancreatic compensatory response to insulin resistance (Reaven 1988 , De Fronzo 1997 . Thus, the observed changes in the -cell mass (increased -cell size, replication rate, and islet neogenesis) of S8 hamsters might represent a pancreatic compensatory response to cope with the increased insulin demand. Although there is a clear overlap between the changes recorded in INGAPpositive cell mass and -cell mass, it is, however, not completely clear which role might play the former in the mechanism of islet response, particularly in its neogenetic component.
There are facts other than these currently described suggesting that INGAP is involved in the process of islet neogenesis.
(1) Administration of a partially purified protein extract isolated from CW pancreata, called ilotropin, caused recapitulation of normal islet ontogeny and reversed STZ diabetes mortality by 50% (Gross et al. 1985 , Pittenger et al. 1991 . (2) A synthetic pentadecapeptide, corresponding to a region unique to INGAP, significantly stimulated thymidine incorporation into the hamster duct epithelium in primary culture and into a rat pancreatic duct cell line, having no effect on a hamster insulinoma tumour cell line (Rafaeloff et al. 1997) . (3) INGAP is the product of a gene expressed in the regenerating hamster pancreas (Rafaeloff et al. 1997) . Western blot analysis demonstrated the presence of INGAP in ilotropin but not in extracts from control pancreata. Finally, (4) ilotropin induced islet neogenesis by a paracrine or autocrine mechanism rather than by a hormonal one (Rosenberg et al. 1983 . Taken together, the available evidence suggests that the INGAP gene is a pancreatic gene whose expression is either triggered (CW hamsters) or enhanced (sucrose-fed hamsters) during islet neogenesis, and that its protein product -a constituent of ilotropin (Pittenger et al. 1991) -is capable of initiating duct cell proliferation and differentiation.
In our sucrose-fed model, INGAP might be the link between the increased insulin demand and pancreatic changes, playing an important regulatory role in islet growth and neogenesis. The present results were obtained with a relatively short-term dietary manipulation, lending further support to the concept that INGAP is a key component in the process of islet neogenesis, and might therefore be considered a potential tool for the treatment of conditions in which -cell mass is seriously decreased or damaged.
